Suppr超能文献

利多卡因与沙丁胺醇联合吸入用于气道麻醉可显著预防反射性支气管收缩。

Combined lidocaine and salbutamol inhalation for airway anesthesia markedly protects against reflex bronchoconstriction.

作者信息

Groeben H, Silvanus M T, Beste M, Peters J

机构信息

Abteilung für Anästhesiologie und Intensivmedizin, Universität Essen, Germany.

出版信息

Chest. 2000 Aug;118(2):509-15. doi: 10.1378/chest.118.2.509.

Abstract

BACKGROUND

Lidocaine inhalation, in subjects with bronchial hyperreactivity, attenuates evoked bronchoconstriction but also irritates airways. Whether salbutamol pretreatment can mitigate airway irritation and whether combined treatment offers more protection than treatment with either drug alone is unknown. Therefore, we evaluated the effects of the inhalation of lidocaine, salbutamol, lidocaine and salbutamol combined, and placebo on an inhalational histamine challenge.

METHODS

Fifteen patients with mild asthma were selected by a screening procedure (ie, a provocative concentration of a substance [histamine aerosol of < 18 mg/mL] causing a 20% fall in FEV(1) [PC(20)]). On 4 different days after pretreatment with the inhalation of lidocaine (5 mg/kg), inhalation of salbutamol (1.5 mg), combined treatment, or placebo, the histamine challenge was repeated.

RESULTS

The baseline FEV(1) after lidocaine inhalation but prior to the histamine challenge decreased by > 5% in 7 of 15 volunteers, with a mean (+/- SD) decrease from 3.82 +/- 0.90 to 3.54 +/- 0.86 L (p = 0.0054). The baseline PC(20) for histamine was 6.4 +/- 4.3 mg/mL. Both lidocaine and salbutamol inhalation significantly increased PC(20) more than twofold (14.9 +/- 13.7 and 16.8 +/- 10.9 mg/mL, respectively; p = 0, 0007) at a lidocaine plasma concentration of 0.7 +/- 0.3 microg/mL. Combined treatment quadrupled the PC(20) to 29.7 +/- 20.3 mg/mL (vs lidocaine, p = 0.002; vs salbutamol, p = 0.003).

CONCLUSIONS

Thus, histamine-evoked bronchoconstriction, as a model of reflex bronchoconstriction, can be significantly attenuated by salbutamol or lidocaine inhalation. However, lidocaine inhalation causes significant initial bronchoconstriction. The combined inhalation of salbutamol and lidocaine prevents the initial bronchoconstriction observed with lidocaine alone and offers even more protection to a histamine challenge than either lidocaine or salbutamol alone. Therefore, the combined inhalation of lidocaine and salbutamol can be recommended to mitigate bronchoconstriction when airway instrumentation is required.

摘要

背景

对于支气管高反应性患者,吸入利多卡因可减轻诱发的支气管收缩,但也会刺激气道。沙丁胺醇预处理是否能减轻气道刺激,以及联合治疗是否比单独使用任何一种药物提供更多保护尚不清楚。因此,我们评估了吸入利多卡因、沙丁胺醇、利多卡因与沙丁胺醇联合使用以及安慰剂对吸入组胺激发试验的影响。

方法

通过筛选程序(即引起FEV(1)下降20%[PC(20)]的物质[组胺气雾剂浓度<18mg/mL]的激发浓度)选择了15名轻度哮喘患者。在吸入利多卡因(5mg/kg)、吸入沙丁胺醇(1.5mg)、联合治疗或安慰剂预处理后的4个不同日子,重复进行组胺激发试验。

结果

15名志愿者中有7名在吸入利多卡因后但在组胺激发试验前的基线FEV(1)下降>5%,平均(±标准差)从3.82±0.90L降至3.54±0.86L(p = 0.0054)。组胺的基线PC(20)为6.4±4.3mg/mL。在利多卡因血浆浓度为0.7±0.3μg/mL时,吸入利多卡因和沙丁胺醇均使PC(20)显著增加两倍以上(分别为14.9±13.7和16.8±10.9mg/mL;p = 0.0007)。联合治疗使PC(20)增加四倍至29.7±20.3mg/mL(与利多卡因相比,p = 0.002;与沙丁胺醇相比,p = 0.003)。

结论

因此,作为反射性支气管收缩模型的组胺诱发的支气管收缩可通过吸入沙丁胺醇或利多卡因显著减轻。然而,吸入利多卡因会引起明显的初始支气管收缩。沙丁胺醇和利多卡因联合吸入可预防单独使用利多卡因时观察到的初始支气管收缩,并且比单独使用利多卡因或沙丁胺醇对组胺激发试验提供更多保护。因此,当需要气道器械操作时,推荐联合吸入利多卡因和沙丁胺醇以减轻支气管收缩。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验